T he factors that initiate coronary artery disease are not well defined. Interactions between the vessel wall and blood elements may play important roles in converting chronic to acute coronary artery disease syndromes.1-3 Platelets contain vasoactive substances such as thromboxane and serotonin that upon Supported by National Heart, Lung, and Blood Institute Ischemic SCOR grant 17699.
suit in cyclical reductions in coronary blood flow.14-16 Clinically, cyclic flow variations have been observed before and after coronary angioplasty in patients with unstable angina.17
In the present study, we assessed the effects of endogenously produced nitric oxide on platelet aggregation and cyclic flow variations in dogs with stenosed and endothelium-injured arteries.
Methods
All procedures used in this study were conducted according to the principles of the American Physiological Society and 'were approved by the Institutional Animal Care and Use Committee at the Texas Heart Institute, Houston, Tex.
Surgical Preparation
Mongrel dogs (n=33) weighing [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Group 3. In nine dogs, saline was infused in the exposed femoral artery for 30 minutes followed by L-NMMA at 5 mg/kg for 15 minutes and then L-arginine at 60 mg/kg for 15 minutes. The cross-sectional area of the lumen of the femoral artery was measured by ultrasonic imaging before and after the infusion of saline, L-NMMA, and L-arginine. The dogs were monitored for a 1-2-hour period of recovery after discontinuation of the treatment. The endothelium of the femoral artery then was injured by squeezing the artery with cushioned forceps, and cylindrical plastic constrictors were placed around the artery to reduce the femoral blood flow velocity to 50% of the baseline level. The degree of stenosis was more severe in the femoral artery because a larger volume of blood flows through the femoral artery than through the coronary artery. Saline was infused in the femoral artery for 30 minutes followed by infusion of L-NMMA at 5 mg/kg for 15 minutes. If cyclic flow variations developed, L-arginine was infused 30 minutes later at a concentration of 60 mg/kg for 15 minutes. The cross-sectional area of the arterial lumen at the site of endothelial injury proximal to the stenosis was measured with ultrasonic imaging before and after the infusion of saline, L-NMMA, and L-arginine. Group 4. In nine dogs, saline was infused in the femoral artery for 30 minutes followed by the infusion of acetylcholine at 1, 10, and 100 gg/min (estimated blood concentration 5.5 x 10'8M, 5.5 x 10-7M, and 5.5 x 10 'M, respectively) each for 5 minutes. The crosssectional area of the arterial lumen was measured before and after saline infusion and after each dose of acetylcholine. The dogs were allowed to recover for 2 hours after the infusion of acetylcholine. The endothelium of the artery then was injured by squeezing the artery with cushioned forceps, and cylindrical plastic constrictors placed around the artery reduced the blood flow velocity to 50% of the baseline level. Saline was infused again followed by acetylcholine at 1, 10, and 100 squeezing the artery with cushioned forceps. The con-,ug/min each for 5 minutes. The cross-sectional area of the arterial lumen at the site of endothelial injury proximal to the stenosis was measured before and after the infusion of saline and each dose of acetylcholine. If In group 3 dogs, administration of acetylcholine caused a dose-dependent vasodilation as illustrated by an incremental increase in the mean cross-sectional area of the femoral artery before endothelial injury ( Figure 5 ). However, administration of acetylcholine after endothelial injury resulted in a dose-dependent vasoconstrictive effect ( Figure 5 ). Acetylcholine did not induce cyclic flow variations in any of the nine dogs with injured endothelia and moderately stenosed (mean blood flow reduced to 50±4% of the baseline level) femoral arteries. An increase in the severity of constriction achieved by adjusting the external constrictor (reducing mean blood flow velocity to 38±7% of the baseline level) caused cyclic flow variations in all nine dogs. Saline infusion did not affect the cyclic flow variations, but infusion of acetylcholine increased their severity as shown by a reduction in the nadir flow velocity of the cyclic flow variations (from 26±6% of baseline level to 11±3%,p<0.01) ( Table 1) .
Effects of NG-Monomethyl-L-arginine, L-Arginine, and Acetylcholine on Platelet Aggregation Ex Vivo and In Vitro
In control samples, collagen induced platelet aggregation in a dose-dependent manner ( Figure 6A ). Treatment with L-NMMA resulted in a higher percentage of platelet aggregation than that observed in control groups when low to moderate doses of collagen were cyclic flow variations in all seven dogs (Figures 1 and 2 ). duced by low to high levels of collagen ( Figure 6A ). In in vitro studies, L-NMMA significantly enhanced platelet aggregation in a dose-dependent manner, whereas L-arginine significantly decreased platelet aggregation ( Figure 6B ). Neither D-arginine nor acetylcholine affected platelet aggregation in vitro ( Figure 6B ). 
Discussion
Group 1 (LAD, n=9) Baseline Stenosed Saline L-NMMA Saline L-Arginine Group 2 (LAD, n=6) Baseline Stenosed Saline L-NMMA Saline L-Arginine Group 3 (femoral artery, n=9) Baseline Saline(B) L-NMMA(B) L-Arginine(B) Stenosed Saline(A) L-NMMA(A) Saline(A) L-Arginine(A)
Conclusions
We have demonstrated that endogenously produced nitric oxide protects against cyclic flow reductions in stenosed and endothelium-injured coronary and femoral arteries by inhibiting platelet aggregation. We have also shown that an endothelium-dependent vasodilator, acetylcholine, constricts femoral arteries with injured endothelium and enhances the severity of cyclic flow reductions.
